To validate the role of these factors in modulating the migration abilities of cancer cells, HOS cells stimulated with CM BM‐MSCs HOS were treated or not treated with neutralizing antibodies against IL‐6, IL‐8, MCP‐1 and SB225002, and then analysed for invasion and transmigration. The gene discussed is CCL2; the disease is cancer.